Gossypol (gossypol) is a yellow polyphenol hydroxydicarboxylic acid aldehyde compound, which mainly exists in the root, stem, leaf and seed of mallow cotton.Gossypol is a polyphenolic substance extracted from the mature seeds and root bark of malvaceous plants, such as grass cotton, tree cotton or uescotton, which has the function of inhibiting spermatogenesis and spermatogenesis.Can be used as an effective male contraceptive.
Highlights
The global Gossypol market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Gossypol is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gossypol is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Gossypol in Male Birth Control Pill is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Gossypol include Nycomed, Shaanxi Panlong Pharmaceutical Group, Xi'an North Pharmaceutical and Harbin Sanlian Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gossypol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gossypol.
The Gossypol market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gossypol market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gossypol companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Nycomed
Shaanxi Panlong Pharmaceutical Group
Xi'an North Pharmaceutical
Harbin Sanlian Pharmaceutical
Segment by Type
CO
Gossypol Acetate
Segment by Application
Male Birth Control Pill
Antitumor Drug
Heavy Or Irregular Periods
Uterine Fibroids
Endometriosis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gossypol companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Gossypol Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CO
1.2.3 Gossypol Acetate
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Gossypol Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Male Birth Control Pill
1.3.3 Antitumor Drug
1.3.4 Heavy Or Irregular Periods
1.3.5 Uterine Fibroids
1.3.6 Endometriosis
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gossypol Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Gossypol Growth Trends by Region
2.2.1 Global Gossypol Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gossypol Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Gossypol Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Gossypol Âé¶¹Ô´´ Dynamics
2.3.1 Gossypol Industry Trends
2.3.2 Gossypol Âé¶¹Ô´´ Drivers
2.3.3 Gossypol Âé¶¹Ô´´ Challenges
2.3.4 Gossypol Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gossypol Players by Revenue
3.1.1 Global Top Gossypol Players by Revenue (2018-2023)
3.1.2 Global Gossypol Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Gossypol Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gossypol Revenue
3.4 Global Gossypol Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Gossypol Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gossypol Revenue in 2022
3.5 Gossypol Key Players Head office and Area Served
3.6 Key Players Gossypol Product Solution and Service
3.7 Date of Enter into Gossypol Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Gossypol Breakdown Data by Type
4.1 Global Gossypol Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Gossypol Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Gossypol Breakdown Data by Application
5.1 Global Gossypol Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Gossypol Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Gossypol Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Gossypol Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gossypol Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Gossypol Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gossypol Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Gossypol Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gossypol Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Gossypol Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gossypol Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Gossypol Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gossypol Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Gossypol Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gossypol Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Gossypol Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gossypol Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Gossypol Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gossypol Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Gossypol Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gossypol Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Gossypol Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nycomed
11.1.1 Nycomed Company Detail
11.1.2 Nycomed Business Overview
11.1.3 Nycomed Gossypol Introduction
11.1.4 Nycomed Revenue in Gossypol Business (2018-2023)
11.1.5 Nycomed Recent Development
11.2 Shaanxi Panlong Pharmaceutical Group
11.2.1 Shaanxi Panlong Pharmaceutical Group Company Detail
11.2.2 Shaanxi Panlong Pharmaceutical Group Business Overview
11.2.3 Shaanxi Panlong Pharmaceutical Group Gossypol Introduction
11.2.4 Shaanxi Panlong Pharmaceutical Group Revenue in Gossypol Business (2018-2023)
11.2.5 Shaanxi Panlong Pharmaceutical Group Recent Development
11.3 Xi'an North Pharmaceutical
11.3.1 Xi'an North Pharmaceutical Company Detail
11.3.2 Xi'an North Pharmaceutical Business Overview
11.3.3 Xi'an North Pharmaceutical Gossypol Introduction
11.3.4 Xi'an North Pharmaceutical Revenue in Gossypol Business (2018-2023)
11.3.5 Xi'an North Pharmaceutical Recent Development
11.4 Harbin Sanlian Pharmaceutical
11.4.1 Harbin Sanlian Pharmaceutical Company Detail
11.4.2 Harbin Sanlian Pharmaceutical Business Overview
11.4.3 Harbin Sanlian Pharmaceutical Gossypol Introduction
11.4.4 Harbin Sanlian Pharmaceutical Revenue in Gossypol Business (2018-2023)
11.4.5 Harbin Sanlian Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Nycomed
Shaanxi Panlong Pharmaceutical Group
Xi'an North Pharmaceutical
Harbin Sanlian Pharmaceutical
Ìý
Ìý
*If Applicable.